abnormal b-cell function in hemophiliacs treated with cryoprecipitate and factor viii and ix concentrates.

NLM AIDSLINE Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentrates. Gorski A; Gjerset GF; Martin PJ; Counts RB; Hansen JA
November 30, 1986

Clin Immunol Immunopathol. 1986 Sep;40(3):447-55. Unique Identifier : B-Cell function was evaluated in a group of 43 patients with factor VIII or factor IX deficiency. Thirty had been treated primarily with cryoprecipitate and 13 with concentrates of factor VIII or IX. Serum immunoglobulin G levels were found to be diffusely elevated; however, the absolute number of mature B cells in peripheral blood was normal. B-Cell function as measured by testing mitogen-induced proliferation and and immunoglobulin secretion by plaque-forming cells (PFC) in vitro was reduced. Coculture experiments suggested that these abnormal B-cell responses might be secondary to increased suppressor T-cell activity, which was found more frequently in patients seropositive for antibody to lymphadenopathy-associated virus. Both seronegative and seropositive patients had reduced responses in the proliferative and PFC assays, but the lowest PFC responses occurred in the seropositive group. Adolescence Adult Aged B-Lymphocytes/IMMUNOLOGY Child Christmas Disease/IMMUNOLOGY Factor IX/THERAPEUTIC USE Factor VIII/THERAPEUTIC USE Fibrinogen/THERAPEUTIC USE Hemolytic Plaque Technique Hemophilia/DRUG THERAPY/*IMMUNOLOGY Human IgG/ANALYSIS Middle Age Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Fight Breast Cancer and More at Walk The World, A First of Its Kind Walkathon at The Walt Disney World Resort in Florida When it comes to deadly viruses, what's in a name?Policy change has yet to affect HIV-positive sailors Immune system cancer drugs tipped to be a $35 billion market Accidental find shows Vitamin C kills tuberculosis Study Finds Vitamin C Can Kill Drug-Resistant TB Big jump in HIV among Navajo in New Mexico Peace Corps to accept same-sex couples UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall COLORADO: Boulder Groups Honor More Than 150 Local AIDS Victims PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic(R), SB-728-T Canada, Uganda test drug to treat brain disease Less-used drug better treats HIV in kids: study MALAWI: Marriage Is a Risk Factor for HIV Infection in Malawi JAPAN: Daclatasvir/Asunaprevir Effective in Difficult-to-Treat HCV Populations BELGIUM: Long-Term Suppression of Viral Load and Sustained CD4 Cell Increase Reduce Risk of Cervical HPV Infection for HIV-Positive Women Study: Widespread 'test-and-treat' HIV policies could increase dangerous drug resistance Agency Reviews Patent Application Approval Request for "Methods for Treatment of HIV and Other Infections Using a T Cell Or Viral Activator and Anti-Retroviral Combination Therapy"UNITED STATES: Pfizer's Drug to Treat Tuberculosis in Short Supply
Information in this article was accurate in November 30, 1986. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.